296 related articles for article (PubMed ID: 33301485)
1. Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty.
Shim YS; Lim KI; Lee HS; Hwang JS
PLoS One; 2020; 15(12):e0243212. PubMed ID: 33301485
[TBL] [Abstract][Full Text] [Related]
2. Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty.
Lee HS; Yoon JS; Park KJ; Hwang JS
PLoS One; 2018; 13(8):e0201906. PubMed ID: 30133462
[TBL] [Abstract][Full Text] [Related]
3. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
Lanes R; Soros A; Jakubowicz S
J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.
Pucarelli I; Segni M; Ortore M; Arcadi E; Pasquino AM
J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1005-10. PubMed ID: 14513877
[TBL] [Abstract][Full Text] [Related]
5. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
Pucarelli I; Segni M; Ortore M; Moretti A; Iannaccone R; Pasquino AM
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
[TBL] [Abstract][Full Text] [Related]
7. Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results.
Mul D; Bertelloni S; Carel JC; Saggese G; Chaussain JL; Oostdijk W
Horm Res; 2002; 58(1):1-7. PubMed ID: 12169774
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of auxological parameters, adult height outcome and its determinants in leuprolide-treated Indian girls with idiopathic central precocious puberty.
Mondkar S; Khadilkar V; Yewale S; Dange N; More C; Khadilkar A
J Pediatr Endocrinol Metab; 2024 Jan; 37(1):62-68. PubMed ID: 38008794
[TBL] [Abstract][Full Text] [Related]
10. Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty.
Yoo E; Kim S; Jung HL; Shim JY; Shim JW; Kim DS; Kwak JH; Kim ES; Yang A
Front Endocrinol (Lausanne); 2023; 14():1134977. PubMed ID: 36875449
[TBL] [Abstract][Full Text] [Related]
11. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty.
Tung YC; Lee JS; Tsai WY; Hsiao PH
J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961
[TBL] [Abstract][Full Text] [Related]
12. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
[TBL] [Abstract][Full Text] [Related]
13. Near final height after GnRH agonist treatment in central precocious puberty.
Micillo M; Salerno M; Officioso A; Perna E; Gasparini N; Pisaturo L; Di Maio S
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():787-90. PubMed ID: 10969922
[TBL] [Abstract][Full Text] [Related]
14. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
Massart F; Federico G; Harrell JC; Saggese G
Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
[TBL] [Abstract][Full Text] [Related]
15. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
Bertelloni S; Baroncelli GI; Sorrentino MC; Perri G; Saggese G
Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
[TBL] [Abstract][Full Text] [Related]
16. Treatment of central precocious puberty: lessons from a 15 years prospective trial. German Decapeptyl Study Group.
Partsch CJ; Heger S; Sippell WG
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():747-58. PubMed ID: 10969917
[TBL] [Abstract][Full Text] [Related]
17. Using change in predicted adult height during GnRH agonist treatment for individualized treatment decisions in girls with central precocious puberty.
Trujillo MV; Lee PA; Reifschneider K; Backeljauw PF; Dragnic S; Van Komen S; Yu J; Klein KO
J Pediatr Endocrinol Metab; 2023 Mar; 36(3):299-308. PubMed ID: 36473097
[TBL] [Abstract][Full Text] [Related]
18. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.
Liang Y; Wei H; Li J; Hou L; Zhang J; Wu W; Ying Y; Luo X
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):839-46. PubMed ID: 25719299
[TBL] [Abstract][Full Text] [Related]
19. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes of Treatments for Central Precocious Puberty or Early and Fast Puberty in Chinese Girls.
Fu J; Zhang J; Chen R; Ma X; Wang C; Chen L; Liang Y; Luo X; Yang Y; Xiong F; Su Z; Wu J; Yao H; Xu J; Wu D; Ni Y
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31702013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
